Cite
HARVARD Citation
Carlsson, G. et al. (n.d.). 569PISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. Annals of oncology. p. . [Online].